Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT00568685 · COMPLETED
Trial details
- NCT number
- NCT00568685
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-11-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.